BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2534966)

  • 1. The "double grafted tumor system", proposed to find effector cells in the analyses of antitumor effect of BRMs.
    Kohya H; Ebina T; Yamaguchi T; Ishida N
    Biotherapy; 1989; 1(3):139-51. PubMed ID: 2534966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Differences of antitumor effect of various BRMs by intratumoral administration].
    Ebina T; Murata K
    Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1429-32. PubMed ID: 1530288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differences in antitumor effect of various BRMs by intratumoral administration: induction of immunosuppressive acidic protein].
    Ebina T; Murata K
    Gan To Kagaku Ryoho; 1993 Aug; 20(11):1453-6. PubMed ID: 8373204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antitumor effect of PSK (2): effector mechanism of the antimetastatic effect in the "double grafted tumor system"].
    Ebina T; Kohya H
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1847-53. PubMed ID: 3592718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effector mechanism at a distant site in the double grafted tumor system of PSK, a protein-bound polysaccharide preparation.
    Ebina T; Kohya H
    Jpn J Cancer Res; 1988 Aug; 79(8):957-64. PubMed ID: 3141330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of intratumoral administration of biological response modifiers: induction of immunosuppressive acidic protein, a type of alpha 1-acid glycoprotein, in mice.
    Ebina T; Murata K; Tamura K
    Jpn J Cancer Res; 1994 Jan; 85(1):93-100. PubMed ID: 8106294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimetastatic effect of biological response modifiers in the "double grafted tumor system".
    Ebina T; Kohya H; Yamaguchi T; Ishida N
    Jpn J Cancer Res; 1986 Oct; 77(10):1034-42. PubMed ID: 3096919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor effect of interleukin-1 beta in the double grafted tumor system.
    Ebina T; Ishikawa K
    Jpn J Cancer Res; 1989 Jun; 80(6):570-6. PubMed ID: 2503477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antitumor effect of a novel antitumor compound, NC-190, in the double grafted tumor system].
    Ebina T; Shishido K; Murata K
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1345-50. PubMed ID: 2369138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor effect of PSK (1). Interferon-inducing activity and intratumoral administration].
    Ebina T; Kohya H; Inoue H; Aso H
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1841-6. PubMed ID: 2439019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents.
    Ebina T; Murata K
    Jpn J Cancer Res; 1992 Jul; 83(7):775-82. PubMed ID: 1517151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antitumor effect of Cepharanthin in the double grafted tumor system].
    Ebina T; Ishikawa K; Murata K
    Gan To Kagaku Ryoho; 1990 Jun; 17(6):1165-71. PubMed ID: 2350192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor effect of PSK: role of regional lymph nodes and enhancement of concomitant and sinecomitant immunity in the mouse.
    Ebina T; Kohya H; Ishikawa K
    Jpn J Cancer Res; 1989 Feb; 80(2):158-66. PubMed ID: 2498250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effect of PSK at a distant site: inductions of interleukin-8-like factor and macrophage chemotactic factor in murine tumor.
    Ebina T; Murata K
    Jpn J Cancer Res; 1990 Dec; 81(12):1307-13. PubMed ID: 2126000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice.
    Ebina T; Fujimiya Y
    Biotherapy; 1998; 11(4):259-65. PubMed ID: 9950102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Regional adoptive immunotherapy using activated lymphocytes].
    Ebina T; Isono N; Murata K; Yokoyama J; Mikuni J; Ohuchi K
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1549-52. PubMed ID: 8854802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in cellular composition induced by neocarzinostatin pretreatment in Meth A-bearing mice and the responsible antitumor effector cells.
    Masuda E; Shishido T; Fujimoto R; Maeda H
    Immunopharmacology; 1997 Aug; 37(1):105-16. PubMed ID: 9285249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic therapeutic effect of combination therapy with OK-432 and interferon-alpha or -gamma on Meth-A ascites tumor in BALB/c mice.
    Mizushima Y; Morikage T; Hirata H; Sato M; Sakamoto K; Yano S
    J Biol Response Mod; 1988 Aug; 7(4):371-83. PubMed ID: 3139841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activation and regulation of macrophages induced by inoculation of cryodestroyed tumor cells].
    Tsujino M
    Osaka Daigaku Shigaku Zasshi; 1990 Jun; 35(1):180-205. PubMed ID: 2135404
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eradication of syngeneic tumor (Meth A fibrosarcoma) from mice by adoptive immunotherapy of immunized spleen cells induced by Corynebacterium parvum-pyridine extract residue.
    Mukai K; Horimi T; Orita K
    Acta Med Okayama; 1988 Dec; 42(6):301-10. PubMed ID: 3266420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.